journal article·2022-05

The anti-inflammatory and osteogenic activity of chitosan/polyvinyl alcohol/graphene oxide/astaxanthin nanofibers membranes in vitro study

Xuan Dang, Hengfang Zhang, Lexun Lin, Pei Li, Liping Ren, Wei Zhang, Rong Song

Publisher page

Abstract

Anti-inflammation and bone regeneration are the two major goals of periodontal therapy. We have demonstrated that chitosan (CS)/polyvinyl alcohol (PVA)/graphene oxide (GO)/astaxanthin (ASTA) nanofibers membranes prepared by electrospinning had favorable micro-morphology, good mechanical properties, and no cytotoxicity. In this study, CS/PVA/GO/ASTA nanofibers membranes were prepared to modulate both inflammatory response and osteogenic induction in vitro study. When the nanofibers membranes were co-cultured with RAW264.7 cells, glycoprotein nonmetastatic melanoma protein in the cells was highly expressed and RAW264.7 cells were polarized to M2 phenotype at the same time. In addition, following stimulation with nanofibers membranes, the messenger RNA (mRNA) and protein levels of Osteocalcin (OCN) and Runx2 in Bone marrow mesenchymal stem cells (BMSCs) were highly expressed. Taken together, these results suggested CS/PVA/GO/ASTA nanofibers membranes may promote the dissipation of inflammation and stimulate the differentiation of BMSCs into osteoblasts.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

First Affiliated Hospital of Harbin Medical University, College of Stomatology, Harbin Medical University, Harbin, China

Department of pathogenic biology teaching center, Basic Medical College, Harbin Medical University, Harbin, China

Institute of Materials Science and Engineering, Northeast Forestry University, Harbin, 150040

References (30)

Show source-provided references
1. 10.1007/s10753-019-00977-410.1007/s10753-019-00977-4 ↗
2. 10.1111/j.1600-051X.2008.01263.x10.1111/j.1600-051X.2008.01263.x ↗
3. 10.1128/IAI.01131-1510.1128/IAI.01131-15 ↗
4. 10.1177/002203451880598410.1177/0022034518805984 ↗
5. 10.1016/j.jconrel.2020.01.04510.1016/j.jconrel.2020.01.045 ↗
6. 10.1016/j.actbio.2020.12.04610.1016/j.actbio.2020.12.046 ↗
7. 10.1016/j.nbd.2018.08.01310.1016/j.nbd.2018.08.013 ↗
8. 10.1038/srep1692010.1038/srep16920 ↗
9. 10.4049/jimmunol.178.10.655710.4049/jimmunol.178.10.6557 ↗
10. 10.3390/cells806053710.3390/cells8060537 ↗
11. 10.25122/jml-2019-003210.25122/jml-2019-0032 ↗
12. 10.1166/jbn.2018.246510.1166/jbn.2018.2465 ↗
13. 10.1016/j.colsurfa.2012.05.01810.1016/j.colsurfa.2012.05.018 ↗
14. 10.1016/j.ijbiomac.2020.03.20710.1016/j.ijbiomac.2020.03.207 ↗
15. 10.1016/j.jnutbio.2018.09.00510.1016/j.jnutbio.2018.09.005 ↗
16. 10.2147/IJN.S18766410.2147/IJN.S187664 ↗
17. 10.1007/s00394-009-0056-410.1007/s00394-009-0056-4 ↗
18. Hasan A · Comb Chem High Throughput Screen · 2020 · 24 · 1243
19. 10.1097/CM9.000000000000081410.1097/CM9.0000000000000814 ↗
20. 10.1016/j.msec.2019.11013710.1016/j.msec.2019.110137 ↗
21. 10.1021/acsomega.1c0136410.1021/acsomega.1c01364 ↗
22. Erika N · Int Journal Nanomedicine · 2016 · 11 · 2265
23. Hengfang Z · J Appl Polym Sci · 2020 · 138
24. 10.1016/j.steroids.2017.10.01310.1016/j.steroids.2017.10.013 ↗
25. 10.1038/nature0587710.1038/nature05877 ↗
26. 10.1016/j.jid.2017.08.03410.1016/j.jid.2017.08.034 ↗
27. 10.1186/s12931-018-0891-z10.1186/s12931-018-0891-z ↗
28. 10.1096/fj.201700629R10.1096/fj.201700629R ↗
29. 10.1016/j.cellimm.2017.03.00610.1016/j.cellimm.2017.03.006 ↗
30. Adriana DB · Clin dev immunol · 2013 · 2013 · 503754